AAAAAA
Results: 1-25/47
Authors:
DOUDET DJ
CHAN GLY
HOLDEN JE
MCGEER EG
AIGNER TA
WYATT RJ
RUTH TJ
Citation: Dj. Doudet et al., 6-[F-18]FLUORO-L-DOPA PET STUDIES OF THE TURNOVER OF DOPAMINE IN MPTP-INDUCED PARKINSONISM IN MONKEYS, Synapse, 29(3), 1998, pp. 225-232
Authors:
MCGEER EG
MCGEER PL
Citation: Eg. Mcgeer et Pl. Mcgeer, MINIREVIEW - THE IMPORTANCE OF INFLAMMATORY MECHANISMS IN ALZHEIMER-DISEASE, Experimental gerontology, 33(5), 1998, pp. 371-378
Authors:
MCGEER EG
MCGEER PL
Citation: Eg. Mcgeer et Pl. Mcgeer, THE FUTURE USE OF COMPLEMENT INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISEASES, Drugs, 55(6), 1998, pp. 739-746
Authors:
YASOJIMA K
SCHWAB C
MCGEER EG
MCGEER PL
Citation: K. Yasojima et al., HUMAN HEART GENERATES COMPLEMENT PROTEINS THAT ARE UP-REGULATED AND ACTIVATED AFTER MYOCARDIAL-INFARCTION, Circulation research, 83(8), 1998, pp. 860-869
Authors:
TAKAMI K
MATSUO A
TERAI K
WALKER DG
MCGEER EG
MCGEER PL
Citation: K. Takami et al., FIBROBLAST-GROWTH-FACTOR RECEPTOR-1 EXPRESSION IN THE CORTEX AND HIPPOCAMPUS IN ALZHEIMERS-DISEASE, Brain research, 802(1-2), 1998, pp. 89-97
Authors:
WALKER DG
TERAI K
MATSUO A
BEACH TG
MCGEER EG
MCGEER PL
Citation: Dg. Walker et al., IMMUNOHISTOCHEMICAL ANALYSES OF FIBROBLAST-GROWTH-FACTOR RECEPTOR-1 IN THE HUMAN SUBSTANTIA-NIGRA - COMPARISON BETWEEN NORMAL AND PARKINSONS-DISEASE CASES, Brain research, 794(2), 1998, pp. 181-187
Authors:
WALKER DG
BEACH TG
XU R
LILE J
BECK KD
MCGEER EG
MCGEER PL
Citation: Dg. Walker et al., EXPRESSION OF THE PROTOONCOGENE RET, A COMPONENT OF THE GDNF RECEPTORCOMPLEX, PERSISTS IN HUMAN SUBSTANTIA-NIGRA NEURONS IN PARKINSONS-DISEASE, Brain research, 792(2), 1998, pp. 207-217
Authors:
MATSUO A
AKIGUCHI I
LEE GC
MCGEER EG
MCGEER PL
KIMURA J
Citation: A. Matsuo et al., MYELIN DEGENERATION IN MULTIPLE SYSTEM ATROPHY DETECTED BY UNIQUE ANTIBODIES, The American journal of pathology, 153(3), 1998, pp. 735-744
Authors:
MCGEER EG
MCGEER PL
Citation: Eg. Mcgeer et Pl. Mcgeer, INFLAMMATORY CYTOKINES IN THE CNS - POSSIBLE ROLE IN THE PATHOGENESISOF NEURODEGENERATIVE DISORDERS AND THERAPEUTIC IMPLICATIONS, CNS DRUGS, 7(3), 1997, pp. 214-228
Authors:
MCGEER EG
MCGEER PL
Citation: Eg. Mcgeer et Pl. Mcgeer, THE ROLE OF THE IMMUNE-SYSTEM IN NEURODEGENERATIVE DISORDERS, Movement disorders, 12(6), 1997, pp. 855-858
Authors:
MCGEER EG
MCGEER PL
Citation: Eg. Mcgeer et Pl. Mcgeer, AGING, NEURODEGENERATIVE DISEASE AND THE BRAIN, Canadian journal on aging, 16(2), 1997, pp. 218-236
Authors:
MCGEER PL
SCHWAB C
MCGEER EG
HADDOCK RL
STEELE JC
Citation: Pl. Mcgeer et al., FAMILIAL NATURE AND CONTINUING MORBIDITY OF THE AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM DEMENTIA COMPLEX OF GUAM, Neurology, 49(2), 1997, pp. 400-409
Authors:
MCGEER PL
SCHULZER M
MCGEER EG
Citation: Pl. Mcgeer et al., STEROID-THERAPY IN AD - REPLY, Neurology, 48(5), 1997, pp. 1474-1474
Authors:
TERAI K
WALKER DG
MCGEER EG
MCGEER PL
Citation: K. Terai et al., NEURONS EXPRESS PROTEINS OF THE CLASSICAL COMPLEMENT PATHWAY IN ALZHEIMER-DISEASE, Brain research, 769(2), 1997, pp. 385-390
Authors:
SHEN Y
LI R
MCGEER EG
MCGEER PL
Citation: Y. Shen et al., NEURONAL EXPRESSION OF MESSENGER-RNAS FOR COMPLEMENT PROTEINS OF THE CLASSICAL PATHWAY IN ALZHEIMER BRAIN, Brain research, 769(2), 1997, pp. 391-395
Authors:
MCGEER PL
WALKER DG
PITAS RE
MAHLEY RW
MCGEER EG
Citation: Pl. Mcgeer et al., APOLIPOPROTEIN E4 (APOE4) BUT NOT APOE3 OR APOE2 POTENTIATES BETA-AMYLOID PROTEIN-ACTIVATION OF COMPLEMENT IN-VITRO, Brain research, 749(1), 1997, pp. 135-138
Authors:
MATSUO A
LEE GC
TERAI K
TAKAMI K
HICKEY WF
MCGEER EG
MCGEER PL
Citation: A. Matsuo et al., UNMASKING OF AN UNUSUAL MYELIN BASIC-PROTEIN EPITOPE DURING THE PROCESS OF MYELIN DEGENERATION IN HUMANS - A POTENTIAL MECHANISM FOR THE GENERATION OF AUTOANTIGENS, The American journal of pathology, 150(4), 1997, pp. 1253-1266
Authors:
SCHWAB C
STEELE JC
MCGEER EG
MCGEER PL
Citation: C. Schwab et al., AMYLOID-P IMMUNOREACTIVITY PRECEDES C4D DEPOSITION ON EXTRACELLULAR NEUROFIBRILLARY TANGLES, Acta Neuropathologica, 93(1), 1997, pp. 87-92
Authors:
YASUHARA O
SCHWAB C
MATSUO A
KIM SU
STEELE JC
AKIGUCHI I
KIMURA J
MCGEER EG
MCGEER PL
Citation: O. Yasuhara et al., MIDKINE-LIKE IMMUNOREACTIVITY IN EXTRACELLULAR NEUROFIBRILLARY TANGLES IN BRAINS OF PATIENTS WITH PARKINSONISM-DEMENTIA COMPLEX OF GUAM, Neuroscience letters, 205(2), 1996, pp. 107-110
Authors:
MCGEER PL
SCHULZER M
MCGEER EG
Citation: Pl. Mcgeer et al., ARTHRITIS AND ANTIINFLAMMATORY AGENTS AS POSSIBLE PROTECTIVE FACTORS FOR ALZHEIMERS-DISEASE - A REVIEW OF 17 EPIDEMIOLOGIC STUDIES, Neurology, 47(2), 1996, pp. 425-432
Authors:
MCGEER PL
MCGEER EG
Citation: Pl. Mcgeer et Eg. Mcgeer, IMMUNE-MECHANISMS IN NEURODEGENERATIVE DISORDERS, Medicamentos de actualidad, 32(2), 1996, pp. 149-158
Authors:
TERAI K
MATSUO A
MCGEER EG
MCGEER PL
Citation: K. Terai et al., ENHANCEMENT OF IMMUNOREACTIVITY FOR NF-KAPPA-B IN HUMAN CEREBRAL INFARCTIONS, Brain research, 739(1-2), 1996, pp. 343-349
Authors:
MCGEER PL
MCGEER EG
Citation: Pl. Mcgeer et Eg. Mcgeer, THE INFLAMMATORY RESPONSE SYSTEM OF BRAIN - IMPLICATIONS FOR THERAPY OF ALZHEIMER AND OTHER NEURODEGENERATIVE DISEASES, Brain research reviews, 21(2), 1995, pp. 195-218
Authors:
WALKER DG
YASUHARA O
PATSTON PA
MCGEER EG
MCGEER PL
Citation: Dg. Walker et al., COMPLEMENT C1 INHIBITOR IS PRODUCED BY BRAIN-TISSUE AND IS CLEAVED INALZHEIMER-DISEASE, Brain research, 675(1-2), 1995, pp. 75-82
Authors:
SCHWAB C
STEELE JC
AKIYAMA H
MCGEER EG
MCGEER PL
Citation: C. Schwab et al., RELATIONSHIP OF AMYLOID-BETA A4 PROTEIN TO THE NEUROFIBRILLARY TANGLES IN GUAMANIAN PARKINSONISM-DEMENTIA, Acta Neuropathologica, 90(3), 1995, pp. 287-298